Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astrana HealthASTH +4.95%74 Market Cap is $1,861 Mil as of Aug. 10, 2026. GuruFocus rates ASTH with a GF Score™ of 74/100 and a GF Value™ of $65.38 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 690 Healthcare Providers & Services companies, Astrana Health ranks better than 87.83% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Astrana Health's share price for the quarter that ended in Jun. 2026 was $46.41. Astrana Health's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 50 Mil. Therefore, Astrana Health's market cap for the quarter that ended in Jun. 2026 was $2,310 Mil.
Astrana Health's quarterly market cap
declined
from Dec. 2025 ($1,213 Mil) to Mar. 2026 ($1,200 Mil) but then
increased
from Mar. 2026 ($1,200 Mil) to Jun. 2026 ($2,310 Mil).
Astrana Health's annual market cap
declined
from Dec. 2023 ($1,794 Mil) to Dec. 2024 ($1,511 Mil) and
declined
from Dec. 2024 ($1,511 Mil) to Dec. 2025 ($1,213 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Astrana Health's Enterprise Value for Today is $2,217 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Astrana Health Market Cap Related Terms
Astrana Health Market Cap Historical Data
* Premium members only.
The historical data trend for Astrana Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Astrana Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Astrana Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Astrana Health (ASTH) has a Market Cap of $1,861 Mil as of Aug. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #84 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Astrana Health's Market Cap too high?
Astrana Health's current Market Cap is $1,861 Mil. The Healthcare Providers & Services industry median Market Cap is 106.59. Astrana Health's value of $1,861 Mil is 1645.9% above this industry median. Based on the distribution chart, Astrana Health ranks #84 out of 690 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Astrana Health has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Market Cap compare to SNDA and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #84 out of 690 companies for Market Cap. This places Astrana Health in the top 12% of its industry — outperforming the majority of peers. The industry median Market Cap is 106.59. Astrana Health's value of $1,861 Mil is 1645.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 106.59, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Market Cap of $1,861 Mil is 1645.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 106.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Market Cap is $1,861 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $65.38, compared to a current price of $37.53 — trading 42.6% below its estimated fair value. The current Market Cap is $1,861 Mil and 1645.9% above the Healthcare Providers & Services industry median of 106.59. Astrana Health's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Astrana Health (ASTH), the current Market Cap is $1,861 Mil as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $37.53 is trading 42.6% below its estimated GF Value™ of $65.38.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Market Cap: $1,861 Mil
GF Value™: $65.38 vs. price of $37.53 (42.6% below fair value)
Industry Position: 1645.9% above the Healthcare Providers & Services median (#84 of 690)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
74GF Score
Get the complete analysis for ASTH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
